Trium Capital LLP Dice Therapeutics, Inc. Put Options Transaction History

Trium Capital LLP

  • $350 Million
  • Q3 2024

Put Options

1 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$25.86 - $46.71 $248,256 - $448,416
9,600 New
9,600 $446,000

Others Institutions Holding DICE

# of Institutions
3
Shares Held
17.7K
Call Options Held
13K
Put Options Held
0
View Full List

About DICE Therapeutics, Inc.

DICE Quotes by TradingView
  • Ticker DICE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,430,000
  • Description
  • DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...
More about DICE
Track This Portfolio

Track Trium Capital LLP Portfolio

Follow Trium Capital LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trium Capital LLP, based on Form 13F filings with the SEC.

News

Stay updated on Trium Capital LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email